ID: ALA394707

Max Phase: Preclinical

Molecular Formula: C16H14N6O

Molecular Weight: 306.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1c(N)nc(N2CCOCC2)c(C#N)c1-c1ccncc1

Standard InChI:  InChI=1S/C16H14N6O/c17-9-12-14(11-1-3-20-4-2-11)13(10-18)16(21-15(12)19)22-5-7-23-8-6-22/h1-4H,5-8H2,(H2,19,21)

Standard InChI Key:  FRGUWVSBJRBWNF-UHFFFAOYSA-N

Associated Targets(Human)

HCC 2998 41480 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Malme-3M 44254 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

IGROV-1 47897 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A498 42825 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T47D 39041 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.33Molecular Weight (Monoisotopic): 306.1229AlogP: 1.31#Rotatable Bonds: 2
Polar Surface Area: 111.85Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 1.15CX LogD: 1.15
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.89Np Likeness Score: -1.42

References

1. Cocco MT, Congiu C, Lilliu V, Onnis V..  (2007)  Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives.,  15  (4): [PMID:17142048] [10.1016/j.bmc.2006.11.031]

Source